148 related articles for article (PubMed ID: 38774165)
1. Poor Glycemic Control Affecting Screening of Prostate Carcinoma.
Bharti A; Shekhar R; Prakash P; Kumari S; Kumar S
Cureus; 2024 Apr; 16(4):e58680. PubMed ID: 38774165
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
4. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.
Swami V; Yadav SK; Saxena P; Sharma A; Dash CK; Gupta A
J Assoc Physicians India; 2024 Jan; 72(1):18-21. PubMed ID: 38736069
[TBL] [Abstract][Full Text] [Related]
7. Report of the committee on the classification and diagnostic criteria of diabetes mellitus.
; Seino Y; Nanjo K; Tajima N; Kadowaki T; Kashiwagi A; Araki E; Ito C; Inagaki N; Iwamoto Y; Kasuga M; Hanafusa T; Haneda M; Ueki K
J Diabetes Investig; 2010 Oct; 1(5):212-28. PubMed ID: 24843435
[TBL] [Abstract][Full Text] [Related]
8. Impact of poor glycemic control of type 2 diabetes mellitus on serum prostate-specific antigen concentrations in men.
Atalay HA; Akarsu M; Canat L; Ülker V; Alkan İ; Ozkuvancı U
Prostate Int; 2017 Sep; 5(3):104-109. PubMed ID: 28828353
[TBL] [Abstract][Full Text] [Related]
9. The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions.
Flores-Fraile MC; Padilla-Fernández BY; Valverde-Martínez S; Marquez-Sanchez M; García-Cenador MB; Lorenzo-Gómez MF; Flores-Fraile J
J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33114134
[TBL] [Abstract][Full Text] [Related]
10. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
11. Prostate size correlates with fasting blood glucose in non-diabetic benign prostatic hyperplasia patients with normal testosterone levels.
Kim WT; Yun SJ; Choi YD; Kim GY; Moon SK; Choi YH; Kim IY; Kim WJ
J Korean Med Sci; 2011 Sep; 26(9):1214-8. PubMed ID: 21949470
[TBL] [Abstract][Full Text] [Related]
12. Correlation between prostate volume and prostate-specific antigen in Nigerian men with symptomatic histologically-diagnosed benign prostatic hyperplasia.
Aigbe E; Irekpita E; Ogbetere FE; Alili UI
Niger J Clin Pract; 2022 Sep; 25(9):1523-1528. PubMed ID: 36149214
[TBL] [Abstract][Full Text] [Related]
13. Association between body mass index and hemoglobin A1c with serum prostate-specific antigen level: A retrospective cohort study.
Alhamdan WA; Alsulaiman TA; Alsabti RI; Abdulmowla OM; Elnaggar SE; Alendijani Y
Saudi Med J; 2023 Sep; 44(9):870-874. PubMed ID: 37717968
[TBL] [Abstract][Full Text] [Related]
14. Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.
Steuber T; Nurmikko P; Haese A; Pettersson K; Graefen M; Hammerer P; Huland H; Lilja H
J Urol; 2002 Nov; 168(5):1917-22. PubMed ID: 12394676
[TBL] [Abstract][Full Text] [Related]
15. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific Antigen Levels in Moroccan Diabetic Males: A Cross-sectional Study.
Ainahi A; Brakat A; Wakrim L; Mohammadi H; ElMdaghri N; Ezzikouri S
Curr Diabetes Rev; 2018; 14(3):286-290. PubMed ID: 28124607
[TBL] [Abstract][Full Text] [Related]
17. Effects of replacing metformin with pioglitazone on glycemic control in japanese patients with poorly controlled type 2 diabetes mellitus: A 12-week, open-label, prospective study.
Sakaue S; Kamigaki M; Yoshimura H; Nishimura M
Curr Ther Res Clin Exp; 2008 Aug; 69(4):364-77. PubMed ID: 24692813
[TBL] [Abstract][Full Text] [Related]
18. Serum testosterone in Nigerian men with type 2 diabetes mellitus and its relationship with insulin sensitivity and glycemic control.
Sepu N; Adeleye JO; Kuti MO
J Natl Med Assoc; 2021 Jun; 113(3):285-293. PubMed ID: 33353658
[TBL] [Abstract][Full Text] [Related]
19. Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results.
Beckmann K; Crawley D; Nordström T; Aly M; Olsson H; Lantz A; Binti Abd Jalal N; Garmo H; Adolfsson J; Eklund M; Van Hemelrijck M
JAMA Netw Open; 2019 Nov; 2(11):e1914689. PubMed ID: 31693126
[TBL] [Abstract][Full Text] [Related]
20. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen.
Luderer AA; Chen YT; Soriano TF; Kramp WJ; Carlson G; Cuny C; Sharp T; Smith W; Petteway J; Brawer MK
Urology; 1995 Aug; 46(2):187-94. PubMed ID: 7542820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
